5 suspended. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Suspended 5 |
| Phase 2 | 2 | Suspended 2 |
Follow Inflammation: new trials by email Literature Review of Inflammation trials Research Report on Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extracorporal Cytokin Removal in Septic Shock: a Prospective, Randomized, Multicenter Clinical Trial Standard medical therapy, Standard medical therapy plus cytokine removal treatment using Cytosorb, with the adsorber changed in every 12 hours, Standard medical therapy plus cytokine removal treatment using Cytosorb, with the adsorber changed in every 24 hours - Septic Shock | Phase 3 | Suspended | University of Pecs | 135 | 2024-01-01 | 2023-04-20 |
| Hemodynamics Effects of Fludrocortisone on the Pressor Response to Noradrenaline Septic Shock Patients Fludrocortisone, Placebo - Septic Shock | Phase 2 / Phase 3 | Suspended | Rennes University Hospital | 40 | 2022-03-31 | 2023-11-18 |
| Angiotensin II for Septic Shock Treatment Angiotensin II, Normal saline, Norepinephrine - Septic Shock | Phase 3 | Suspended | Cairo University | 20 | 2019-04-01 | 2019-01-16 |
| Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis Talactoferrin alfa, Placebo - Severe Sepsis | Phase 2 / Phase 3 | Suspended | Agennix | 1280 | 2011-06-01 | 2012-02-03 |
| Paracetamol Toxicity in Septic Patients paracetamol, dypirone - Fever, Sepsis | Phase 3 | Suspended | Barzilai Medical Center | 80 | 2010-08-01 | 2011-03-02 |
Sepsis (3) · Shock, Septic (3) · Fever (1)
Infections (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Systemic Inflammatory Response Syndrome (5) · Shock (3) · Sepsis (2) · Body Temperature Changes (1) · Signs and Symptoms (1)
Acetaminophen (1) · Angiotensin II (1) · Dipyrone (1) · Fludrocortisone (1) · Norepinephrine (1) · Saline Solution (1) · talactoferrin alfa (1)
Agennix (1) · Barzilai Medical Center (1) · Cairo University (1) · Rennes University Hospital (1) · University of Pecs (1)
France (2) · Israel (2) · Belgium (1) · Canada (1) · Denmark (1) · Egypt (1) · Germany (1) · Hungary (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)
Ahmed Mukhtar, Professor (1) · Albert Grinshpun (1) · Bruno Laviolle, MD, PhD (1) · Harmonie Perrichet, MD (1)